Shikonin Inhibits the Proliferation of Human Breast Cancer Cells by Reducing Tumor-Derived Exosomes

Shikonin Inhibits the Proliferation of Human Breast Cancer Cells by Reducing Tumor-Derived Exosomes

Shikonin is a naphthoquinone isolated from the traditional Chinese medicine Lithospermum. It has been used in the treatment of various tumors. However, the effects of shikonin on such diseases have not been fully elucidated. In the present study, we detected the exosome release of a breast cancer ce...

Full description

Bibliographic Details
Main Authors:	Yao Wei, Mingzhen Li, Shufang Cui, Dong Wang, Chen-Yu Zhang, Ke Zen, Limin Li
Format:	Article
Language:	English
Published:	MDPI AG 2016-06-01
Series:	Molecules
Subjects:	breast cancer proliferation shikonin exosome miR-128 Bax
Online Access:	http://www.mdpi.com/1420-3049/21/6/777

Similar Items

Exosome-Transmitted miR-128 Targets CCL18 to Inhibit the Proliferation and Metastasis of Urothelial Carcinoma
by: Donghao Shang, et al.
Published: (2022-01-01)

Glutathione-S-transferase enhances proliferation-migration and protects against shikonin-induced cell death in breast cancer cells
by: Shiping He, et al.
Published: (2011-11-01)

Combined Shikonin-Loaded MPEG-PCL Micelles Inhibits Effective Transition of Endothelial-to-Mesenchymal Cells
by: Li G, et al.
Published: (2022-09-01)

Shikonin reduces M2 macrophage population in ovarian cancer by repressing exosome production and the exosomal galectin 3-mediated β-catenin activation
by: Min Wang, et al.
Published: (2024-05-01)

Up-Regulation of p53/miR-628-3p Pathway, a Novel Mechanism of Shikonin on Inhibiting Proliferation and Inducing Apoptosis of A549 and PC-9 Non–Small Cell Lung Cancer Cell Lines
by: Jieli Pan, et al.
Published: (2021-11-01)

Shikonin Inhibits Fin Regeneration in Zebrafish Larvae
by: Zigang Cao, et al.
Published: (2022-10-01)

Shikonin and 4-hydroxytamoxifen synergistically inhibit the proliferation of breast cancer cells through activating apoptosis signaling pathway in vitro and in vivo
by: Hong-Yan Lin, et al.
Published: (2020-03-01)

Experimental Study of Hepatocellular Carcinoma Treatment by Shikonin Through Regulating PKM2
by: Liu T, et al.
Published: (2020-02-01)

Gastric cancer cell-derived exosomal miRNA-128-3p promotes angiogenesis by targeting SASH1
by: Hao Yan, et al.
Published: (2024-11-01)

MiR-128 suppresses metastatic capacity by targeting metadherin in breast cancer cells
by: Danxia Cao, et al.
Published: (2020-09-01)

Upregulation of LncRNA UCA1 promotes cardiomyocyte proliferation by inhibiting the miR-128/SUZ12/P27 pathway
by: Kang Huang, et al.
Published: (2024-07-01)

MiR-128-1-5p inhibits cell proliferation and induces cell apoptosis via targeting PRKCQ in colorectal cancer
by: Qingan Jia, et al.
Published: (2023-12-01)

Pharmacological Effects of Shikonin and Its Potential in Skin Repair: A Review
by: Yanping Song, et al.
Published: (2023-12-01)

Shikonin promotes hypertrophic scar repair by autophagy of hypertrophic scar-derived fibroblasts
by: Qing Zhang, et al.
Published: (2023-10-01)

Shikonin Promotes Skin Cell Proliferation and Inhibits Nuclear Factor-κB Translocation via Proteasome Inhibition In Vitro
by: Yan Yan, et al.
Published: (2015-01-01)

Effects of shikonin on the proliferation and activation of T lymphocytes
by: Xin Liu, et al.
Published: (2018-01-01)

Shikonin inhibits cancer cell cycling by targeting Cdc25s
by: Shoude Zhang, et al.
Published: (2019-01-01)

Exosomal miRNA-128-3p from mesenchymal stem cells of aged rats regulates osteogenesis and bone fracture healing by targeting Smad5
by: Tao Xu, et al.
Published: (2020-03-01)

Shikonin promotes ubiquitination and degradation of cIAP1/2-mediated apoptosis and necrosis in triple negative breast cancer cells
by: Anqi Wang, et al.
Published: (2021-02-01)

Promising Nanomedicines of Shikonin for Cancer Therapy
by: Yan C, et al.
Published: (2023-03-01)

Shikonin ameliorated mice colitis by inhibiting dimerization and tetramerization of PKM2 in macrophages
by: Baoyuan Huang, et al.
Published: (2022-08-01)

Effect and mechanisms of shikonin on breast cancer cells in vitro and in vivo
by: Chuyi Yu, et al.
Published: (2024-11-01)

Exosomal MicroRNA MiR-1246 Promotes Cell Proliferation, Invasion and Drug Resistance by Targeting CCNG2 in Breast Cancer
by: Xiu Juan Li, et al.
Published: (2017-12-01)

Successful in vivo hyperthermal therapy toward breast cancer by Chinese medicine shikonin-loaded thermosensitive micelle
by: Su Y, et al.
Published: (2017-05-01)

Inhibition of the STAT3 Signaling Pathway Contributes to the Anti-Melanoma Activities of Shikonin
by: Hui-Hui Cao, et al.
Published: (2020-05-01)

Evaluation of circulating miRNAs and mRNAs expression patterns in autism spectrum disorder
by: Amany H. Abdelrahman, et al.
Published: (2021-11-01)

Synthesis of Novel Shikonin Derivatives and Pharmacological Effects of Cyclopropylacetylshikonin on Melanoma Cells
by: Christin Durchschein, et al.
Published: (2018-10-01)

Regulations of miR-183-5p and Snail-Mediated Shikonin-Reduced Epithelial-Mesenchymal Transition in Cervical Cancer Cells
by: Tang Q, et al.
Published: (2020-02-01)

Shikonin Inhibits APC-mutant Colon Cancer via Wnt/β-catenin Signaling
by: Lizhe CHEN, et al.
Published: (2024-06-01)

Shikonin attenuates hypoxia-reoxygenation-induced injury of cardiomyocyte cell line H9c2
by: LIU Ming, YANG Chen-li, MENG Qing-xin
Published: (2020-03-01)

Research Progress on Structure and Anti-Gynecological Malignant Tumor of Shikonin
by: Li-Na Ke, et al.
Published: (2022-07-01)

Shikonin mediated anti-acute lung injury and hemostatic effects via inhibiting uPA
by: Chengcheng Li, et al.
Published: (2023-06-01)

Exosome-transmitted miR-30a-5p enhances cell proliferation, migration, and invasion in ovarian cancer
by: Jian Cao, et al.
Published: (2023-11-01)

Deoxyshikonin isolated from Arnebia euchroma inhibits colorectal cancer by down-regulating the PI3K/Akt/mTOR pathway
by: Yuzhen Zhu, et al.
Published: (2019-01-01)

Exosomal miR-361-3p promotes the viability of breast cancer cells by targeting ETV7 and BATF2 to upregulate the PAI-1/ERK pathway
by: Yao Li, et al.
Published: (2024-01-01)

Shikonin inhibits the growth of anaplastic thyroid carcinoma cells by promoting ferroptosis and inhibiting glycolysis
by: Chen Yang, et al.
Published: (2024-07-01)

Shikonin suppresses proliferation of osteosarcoma cells by inducing ferroptosis through promoting Nrf2 ubiquitination and inhibiting the xCT/GPX4 regulatory axis
by: Rui Huang, et al.
Published: (2024-12-01)

Research progress in mechanism of anticancer action of shikonin targeting reactive oxygen species
by: Ke Qi, et al.
Published: (2024-07-01)

Shikonin-loaded PLGA nanoparticles: A promising strategy for psoriasis treatment
by: Jing Fu, et al.
Published: (2024-06-01)

Shikonin sensitizes A549 cells to TRAIL-induced apoptosis through the JNK, STAT3 and AKT pathways
by: Zhi Lan Guo, et al.
Published: (2018-12-01)